News Remedy Meds buys telehealth rival in $500m marriage Telehealth startup Remedy Meds has expanded its position in the US market at a stroke with a $500m-plus deal to buy Thirty Madison.
News Gilead, Amgen kick off facility investments in US This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.
News Ametris starts obesity digital endpoint project with pharma Ametris launches a collaboration with pharma companies that aims to show how digital endpoints can be used in obesity trials.
News 'Brainwave' test raises hopes of early dementia diagnosis A three-minute test could help diagnose people at risk of developing dementia, spotting signs of cognitive decline years before other approaches.
News Uni wins big NIHR grant for healthtech 'horizon scanning' A Newcastle University project that gauges whether health technologies can deliver real changes to the NHS has claimed £22m in UK government funding.
News Scoop: Lumos Labs has FDA nod for ADHD DTx Prismira Lumos Labs has secured its first 510(k) clearance for a digital therapeutics offering, paving the way for entrance into the regulated app market.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
